Back to results
US 6,783,757 B2Granted
Composition and method for increasing exorphin catabolism to treat autism
AssigneeKirkman Group, Inc.
InventorMark A. Brudnak
Life of this patent
Estimating the term…
Abstract
A composition for use in treating autism spectrum disorders. The composition preferably includes a genomeceutical type compound that increases the user's expression of DPPIV or like substances. The genomeceutical compound may include a sugar (such as a milk sugar), glucans, galactose and/or related material. The composition may also include one or more of a protease, peptidase or phytase. The inclusion of phospholipids, disaccharides, lipases and/or related substances in a composition for treating autism spectrum disorders and the function they provide is also disclosed.
Claims5
A composition comprising:
- galactose, an acid fast protease, a peptidase, a cysteine protease and phytase.
Dependencies are inferred from the claim text.